3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Sarcoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Breast Neoplasms
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Patients With Advanced or Metastatic Solid Tumors
1
PRETEXT I Hepatoblastoma
1
Neurofibromatosis 2
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Mesothelial
1
Mouth Neoplasms
1
Melanoma
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Erdheim-Chester Disease
1
Endometrial Adenocarcinoma
1
Endocrine Gland Neoplasms
1
Interventions
Cyclophosphamide
4
Etoposide
3
Vincristine
2
Rituximab
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Doxorubicin
2
fludarabine phosphate
1
Whole-Body Irradiation
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Sirolimus
1
Radiotherapy
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Ganciclovir
1
Foscarnet
1
Flow Cytometry
1
Filgrastim
1
Cyclosporine
1
Carmustine
1
Busulfan
1
Antiviral Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Immunoblastic
×
temsirolimus
×
1 year
×
Clear all
No trials found.